Lilly Alzheimer's Drug Fails, J&J in Acquisition Talks With ALIOF
November 28, 2016 at 11:59 AM EST
Does Johnson & Johnson’s interest in acquiring Actelion imply the beginning of increased merger and acquisition (M&A) activity in the pharma and biotech sector?
